| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 213,565 | 240,949 | 205,842 | 302,362 | | Cost of Revenue | 203,757 | 234,282 | 199,561 | 276,300 | | | Gross Profit | 9,808 | 6,667 | 6,281 | 26,062 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 703 | 1,503 | 222 | 2,659 | | Non Recurring | 198 | 2,732 | 11,861 | (124) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 8,907 | 2,432 | (5,802) | 23,527 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 132 | 261 | 680 | 809 | | Earnings Before Interest And Taxes | 9,039 | 2,693 | (5,122) | 24,336 | | Interest Expense | 425 | 420 | 449 | 430 | | Income Before Tax | 8,614 | 2,273 | (5,571) | 23,906 | | Income Tax Expense | 3,311 | 901 | (1,854) | 6,235 | | Minority Interest | 227 |
-
| 119 | (913) | | | | Net Income From Continuing Ops | 5,530 | 1,372 | (3,598) | 16,758 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 595 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,530 | 1,372 | (3,003) | 16,758 | | Preferred Stock And Other Adjustments | (131) | 131 |
-
|
-
| | | Net Income Applicable To Common Shares | $5,399 | $1,503 | ($3,003) | $16,758 |
|
0.01% Nasdaq 
Income Statement
